Company / R&D Expense
INTERPACE BIOSCIENCES, INC. R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$642.0K
FY2025
5-year range
$335.0K / $1.5M
FY2021-FY2025
Trend
-5.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense has fluctuated over the past 10 years, ranging from $335,000 in FY2023 to $3M in FY2019.
Based on SEC 10-K filings.
$642,000 in FY2025 with a 5-year CAGR of -25.5%.
Improved from $335,000 to $642,000 over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -3.0%
- 5-Year CAGR
- -25.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -25.5%, indicating a declining trend.
- In FY2025, r&d expense decreased 5.0% year-over-year.
- Peak r&d expense was recorded in FY2019.
- Lowest r&d expense in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -2.84 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $642.0K | -5.0% |
| FY2024 | $676.0K | +101.8% |
| FY2023 | $335.0K | -52.3% |
| FY2022 | $703.0K | -52.9% |
| FY2021 | $1.5M | -46.6% |
| FY2020 | $2.8M | -0.5% |
| FY2019 | $2.8M | +32.3% |
| FY2018 | $2.1M | +45.4% |
| FY2017 | $1.5M | -11.3% |
| FY2016 | $1.6M | -28.1% |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026